NCT06554028 2024-08-14
Tislelizumab and Induction Chemotherapy for Larynx Preservation in Resectable Advanced Laryngeal/Hypopharyngeal Cancer
Henan Cancer Hospital
Phase 2 Not yet recruiting
Clinical Trials
4 trialsNCT01700647 2017-09-12
Breath Testing in Early and Late Larynx Cancer
Royal Brisbane and Women's Hospital
Completed
NCT00128817 2013-01-23
Concurrent Chemoradiation Versus Surgery With Adjuvant Therapy in Advanced Laryngopharyngeal Cancers
Tata Memorial Hospital
Phase 3 Terminated
NCT01607138 2012-05-28
Speech and Swallowing Characteristics of Patients After Laryngectomy and the Effect on Quality of Life
Tel-Aviv Sourasky Medical Center
Unknown